Tool
Peptide Comparison
Select 2–3 compounds and see them side by side across every dimension that matters to a research-buying decision — molecular identity, mechanism, half-life, and availability.
Slot 1
GLPMetabolic / Weight
Slot 2
GLPMetabolic / Weight
Slot 3
| Compound | GLP≥ 99% (HPLC) SemaglutideMetabolic / Weight | GLP≥ 99% (HPLC) TirzepatideMetabolic / Weight | Empty slot |
|---|---|---|---|
| Research Profile | |||
| Primary Target | Metabolic / Weight | Metabolic / Weight | — |
| Mechanism | GLP-1 receptor agonist — long-acting fatty acid conjugate | Dual GIP / GLP-1 receptor agonist — fatty-acid acylated | — |
| Estimated Half-Life | ~7 days | ~5 days | — |
| Research Momentum | Score98 | Score96 | — |
| Benefits & Drawbacks | |||
| Benefits |
|
| — |
| Drawbacks |
|
| — |
| Availability & Form | |||
| Form Factors | Lyophilized | Lyophilized | — |
| Availability | Stock95 | Stock92 | — |
| Price / mg | — | — | — |
| Molecular Identity | |||
| Molecular Weight | 4113.5764 g/mol | 4813.5258 g/mol | — |
| CAS Number | 910463-68-2 | 2023788-19-2 | — |
| Molecular Formula | C₁₈₇H₂₉₁N₄₅O₅₉ | C₂₂₅H₃₄₈N₄₈O₆₈ | — |
| Purity | ≥ 99% (HPLC) | ≥ 99% (HPLC) | — |
| Deep Dive | Open briefing | Open briefing | — |
Insight · All selected compounds belong to the GLP family — expect overlapping mechanisms and similar protocol windows.
Molecular identity figures and momentum scores are maintained editorially for research reference. Always verify against primary literature.
